Identifying symptoms of potential issues during tech transfer meetings is the first step to mitigating risks. Key signs can include:Click to read the full article.
The processes within CMOs and CDMOs often reveal symptoms that indicate a need for revisiting acceptance criteria for trial batches. Common signals on the production floor or in the lab…
Identifying problems during the tech transfer process can often stem from multiple sources. Common signals that indicate a failure in the tech transfer process include:Click to read the full article.
Monitoring symptoms of process variability or deviation during manufacturing is essential for maintaining product quality. Professionals should be alert to the following signals:Click to read the full article.
The first step in monitoring process robustness after launching a product through a CDMO is recognizing potential symptoms or signals that indicate issues. Here are some typical signals to look…
Identifying the symptoms or signals that indicate a potential failure during the tech transfer process is crucial for prompt action. Key symptoms can include:Click to read the full article.
During a routine batch release for a new injectable formulation, the Quality Control (QC) team noticed discrepancies in the analytical results that deviated from established specifications. Specifically, potency testing indicated…
Identifying symptoms or signals during a CMO tech transfer is critical to initiating timely corrective actions. Failure signals may manifest through various avenues:Click to read the full article.
Recognizing early symptoms of issues during the CDMO technology transfer process is essential for immediate remediation. Symptoms may arise from either the quality of the product or inconsistencies in the…
The first indicator of issues in a CDMO partnership often presents as discrepancies or deviations in product quality. Signs may include:Click to read the full article.